Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PAGSEG Inc (PAGS) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

PAGSEG IncTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

PAGSEG Inc vs Vaxcyte Inc. Common Stock — how do they compare? PAGSEG Inc trades at $10.83 (market cap $3.03B), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 3.5× PAGSEG Inc's market cap, and PAGSEG Inc pays a 10.19% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PAGSEG Inc for 27 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

PAGSPCVX
Market Cap
$3.03B$10.51B
Volume
2,770,5402,644,694
Sector
IndustrialsHealth
52-Week High
$12.00$73.82
52-Week Low
$8.44$40.32
Typical Hold Time
27 Days0 Days
Enterprise Value
$11.16B$9.14B
Dividend Yield
10.19%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PAGSEG Inc

PAGS trades at $10.99, down 1.35% on the day, with a bullish technical signal from moving averages but overbought short-term RSI readings. The company reported a Q2 2026 EPS beat of $0.41 vs. $0.389 expected, with revenue growth to $20.6B in 2026 and a net income margin of 10.45%. A dividend of $0.28 is scheduled for payment on September 30, 2026.

The stock presents a value opportunity with low P/E (7.31) and P/S (0.76) ratios, supported by strong analyst consensus (62.5% buy ratings) and a $10.70 price target. Key risks include macroeconomic pressures in Brazil and elevated credit losses, but robust cash flow and banking growth underpin long-term potential.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PAGS
0% Buy100% Sell
Avg holding period · 27 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

About PAGSEG Inc

PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.

Read more on PAGS →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →